1. Home
  2. VNCE vs SCYX Comparison

VNCE vs SCYX Comparison

Compare VNCE & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNCE
  • SCYX
  • Stock Information
  • Founded
  • VNCE 2002
  • SCYX 1999
  • Country
  • VNCE United States
  • SCYX United States
  • Employees
  • VNCE N/A
  • SCYX N/A
  • Industry
  • VNCE Clothing/Shoe/Accessory Stores
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VNCE Consumer Discretionary
  • SCYX Health Care
  • Exchange
  • VNCE Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • VNCE 37.1M
  • SCYX 32.3M
  • IPO Year
  • VNCE 2013
  • SCYX 2014
  • Fundamental
  • Price
  • VNCE $2.57
  • SCYX $0.60
  • Analyst Decision
  • VNCE Strong Buy
  • SCYX Strong Buy
  • Analyst Count
  • VNCE 4
  • SCYX 1
  • Target Price
  • VNCE $4.63
  • SCYX $3.00
  • AVG Volume (30 Days)
  • VNCE 195.5K
  • SCYX 579.0K
  • Earning Date
  • VNCE 12-09-2025
  • SCYX 11-05-2025
  • Dividend Yield
  • VNCE N/A
  • SCYX N/A
  • EPS Growth
  • VNCE N/A
  • SCYX N/A
  • EPS
  • VNCE N/A
  • SCYX N/A
  • Revenue
  • VNCE $291,286,000.00
  • SCYX $2,932,000.00
  • Revenue This Year
  • VNCE $1.48
  • SCYX $368.39
  • Revenue Next Year
  • VNCE $4.92
  • SCYX $123.36
  • P/E Ratio
  • VNCE N/A
  • SCYX N/A
  • Revenue Growth
  • VNCE N/A
  • SCYX N/A
  • 52 Week Low
  • VNCE $1.02
  • SCYX $0.59
  • 52 Week High
  • VNCE $6.89
  • SCYX $1.49
  • Technical
  • Relative Strength Index (RSI)
  • VNCE 43.21
  • SCYX 23.32
  • Support Level
  • VNCE $2.73
  • SCYX $0.68
  • Resistance Level
  • VNCE $2.91
  • SCYX $0.82
  • Average True Range (ATR)
  • VNCE 0.16
  • SCYX 0.04
  • MACD
  • VNCE -0.04
  • SCYX -0.01
  • Stochastic Oscillator
  • VNCE 44.29
  • SCYX 2.52

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: